Financial disclosure, insurance, and agreements

The documents nobody reads twice

A monitor finishes reviewing the protocol section of the regulatory binder. The signed protocol is there, the amendments are filed with cross-references, and the Investigator's Brochure has documented receipt and acknowledgment. The monitor flips to the next section and asks a question that should be simple: "Where is the signed clinical trial agreement?"

The coordinator pauses. The agreement was signed months ago -- the site could not have started without it. But where, exactly, is the executed copy? Was it filed in the binder, or did it end up in the institution's contracts office? Is the version in the binder the final version, or a draft that was superseded during negotiations?

I have seen this scenario play out more times than I care to count. The documents covered in this lesson -- financial aspects agreements, financial disclosure forms, insurance statements, and the various signed agreements that underpin a clinical trial -- are not the records that coordinators worry about at three in the morning. They lack the urgency of an IRB approval or the drama of a safety report. But the Essential Records Table does not assign urgency ratings. It assigns asterisks. And every one of these records carries the asterisk, meaning it should generally be in place before the trial begins. During an inspection, a missing clinical trial agreement generates precisely the same regulatory concern as a missing signed protocol.

This lesson covers the filing requirements for each of these records, and then -- because this is the final lesson in the pre-study module -- it teaches you to conduct the completeness verification that serves as your last quality gate before enrollment begins.

The documents nobody reads twice

The documents nobody reads twice

What you will learn

Financial disclosure, insurance, and agreements

The documents nobody reads twice

What you will learn